Literature DB >> 25676690

Four types of fatty acids exert differential impact on pancreatic cancer growth.

Ming Yu1, Hongyi Liu2, Yijie Duan3, Dapeng Zhang2, Shasha Li4, Feng Wang5.   

Abstract

Increased fatty acids (FAs) regulate pancreatic cancer progression, however, the detailed mechanism is not clear, and different forms of FAs may play diversified roles in pancreatic cancer. To elucidate the underlying mechanism, we compared the effects of four major types of FAs on pancreatic cancer growth both in cell culture and in a mouse model. HPAF pancreatic cancer cells were implanted in nude mice for 14 weeks, and the mice were fed with four different high-fat/high-energy diets (15% fat, 4 kcal/g), an iso-caloric diet (5% fat, 4 kcal/g) and a normal diet (4% fat, 3 kcal/g). The high fat diets were rich in saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and n-6 and n-3 polyunsaturated fatty acids (n6- and n3PUFAs), respectively. While n3PUFA diet decreased tumor viability, the other high fat diets stimulated tumor viability by apparently different mechanisms. For instance, xenografts whose carriers were fed with SFA diet had marked expression of cancer-related proteins and lipid droplets. Although mice that were fed with MUFA- and n6PUFA diets had pancreatic tumors of similar size, liver metastasis occurred more frequently in those with the n6PUFA diet. In experiments in vitro, the HPAF-cell population was increased by SFAs and MUFAs, decreased by n3PUFAs and not changed by n6PUFAs. In conclusion, different fatty acids have different impact on pancreatic cancer cells. The effects of fatty acids on pancreatic cancer cells were consistent in vivo and in vitro except that n6PUFAs only had regulatory effects in vivo.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fatty acids; High fat diet; Orthotopic xenograft model; Pancreatic cancer

Mesh:

Substances:

Year:  2015        PMID: 25676690     DOI: 10.1016/j.canlet.2015.02.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

Review 1.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

2.  Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor.

Authors:  Sandeep Nadella; Julian Burks; Abdulhameed Al-Sabban; Gloria Inyang; Juan Wang; Robin D Tucker; Marie E Zamanis; William Bukowski; Narayan Shivapurkar; Jill P Smith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

Review 3.  Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery.

Authors:  Shuhei Shinoda; Naohiko Nakamura; Brett Roach; David A Bernlohr; Sayeed Ikramuddin; Masato Yamamoto
Journal:  Biomedicines       Date:  2022-05-31

4.  Dietary Intake of Fatty Acids and Risk of Pancreatic Cancer: A Case-Control Study.

Authors:  Donghui Li; Jiali Zheng; Rikita Hatia; Manal Hassan; Carrie R Daniel
Journal:  J Nutr       Date:  2022-02-08       Impact factor: 4.687

5.  KRAS Controls Pancreatic Cancer Cell Lipid Metabolism and Invasive Potential through the Lipase HSL.

Authors:  Cody N Rozeveld; Katherine M Johnson; Lizhi Zhang; Gina L Razidlo
Journal:  Cancer Res       Date:  2020-08-19       Impact factor: 12.701

6.  A Prospective Analysis of Intake of Red and Processed Meat in Relation to Pancreatic Cancer among African American Women.

Authors:  Jessica L Petrick; Nelsy Castro-Webb; Hanna Gerlovin; Traci N Bethea; Shanshan Li; Edward A Ruiz-Narváez; Lynn Rosenberg; Julie R Palmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-01       Impact factor: 4.254

Review 7.  Lipidome in colorectal cancer.

Authors:  Guifang Yan; Liqi Li; Bo Zhu; Yongsheng Li
Journal:  Oncotarget       Date:  2016-05-31

Review 8.  Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells.

Authors:  Yoshiaki Sunami; Artur Rebelo; Jörg Kleeff
Journal:  Cancers (Basel)       Date:  2017-12-23       Impact factor: 6.639

Review 9.  KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism.

Authors:  Isaac James Muyinda; Jae-Gwang Park; Eun-Jung Jang; Byong-Chul Yoo
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

Review 10.  The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.

Authors:  Shun Wang; Yan Zheng; Feng Yang; Le Zhu; Xiao-Qiang Zhu; Zhe-Fang Wang; Xiao-Lin Wu; Cheng-Hui Zhou; Jia-Yan Yan; Bei-Yuan Hu; Bo Kong; De-Liang Fu; Christiane Bruns; Yue Zhao; Lun-Xiu Qin; Qiong-Zhu Dong
Journal:  Signal Transduct Target Ther       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.